Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 30, 2006

ReNeuron Inks Collaboration Agreement with CellSeed

  • ReNeuron and CellSeed signed a collaboration agreement to develop liver-cell culture systems for drug safety screening in the pharmaceutical industry.

    The development work, to be conducted in CellSeed’s laboratories in Tokyo, will establish protocols for developing ReNeuron’s ReNcell™ HEP hepatocyte cell-lines in combination with CellSeed’s UpCell and HydroCell temperature-sensitive polymer products for 3-D functional liver tissue.

    3-D liver culture systems represent a way to assay for human liver toxicity of new drugs. The collaboration will enable the joint development of human cell-based drug discovery products for use in the pharmaceutical industry.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »